Global Burn Treatment Market Size, Status and Forecast 2021-2027

Burns are a global public health problem, causing an estimated 180,000 deaths each year.Most of these occur in low - and middle-income countries, with about two-thirds occurring in the who region of Africa and south-east Asia.Burn death rates are falling in many high-income countries.Burns now kill more than seven times as many children in low - and middle-income countries as in high-income countries.Non-fatal burns are a major risk factor, causing prolonged hospitalization, disfigurement and disability, and often leading to stigma and ostracism.
Burn is a common traumatic disease caused by physical or chemical factors such as heat, chemistry, electricity and radiation.Small area burns only cause damage to the skin and/or mucosal tissue or the corresponding deep tissue.However, burns with a large area can cause different degrees of functional, metabolic and morphological changes in each system of the body, resulting in severe systemic reactions and visceral damage, shock, sepsis and multi-organ functional failure, and high mortality.The process of wound healing and treatment is complex and takes a long time.After wound healing, scar contracture and dysfunction are left behind.Therefore, burns, especially large area burns, are one of the most complex and serious traumatic diseases.Want good treatment of large area severe burn patients, in addition to the need of specialized subject doctor has solid basis of specialist burns the medical knowledge and experience, still need to have other departments such as general surgery, heart surgery, urology, orthopedics, anesthesia and medical cooperation consultation, treatment, forming a team, to be successful, it's the result of collective effort cooperation and work together.With the development of modern industry and the renewal of burning weapons, the proportion of burn casualties in peacetime sickness will increase day by day.In daily life, production activities or fire accidents can be seen scattered or in groups of burn victims.
The competition is intense.The big suppliers account for only 50% of the market by 2019.3M, Molnlycke Health Care, Smith & Nephew, ConvaTec, Paul Hartmann are industry leaders.

Market Analysis and Insights: Global Burn Treatment Market
The global Burn Treatment market size is projected to reach US$ 4130.3 million by 2027, from US$ 2955 million in 2020, at a CAGR of 4.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Burn Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Burn Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Burn Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Burn Treatment market.

Global Burn Treatment Scope and Market Size
Burn Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Burn Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug
Dressing
Surgery
Other
Burns are treated with medication, dressings, surgery and others.Dressings accounted for the largest proportion, accounting for nearly 59.6% of the total market in 2019.

Segment by Application
Hospital
Clinic
Other
Burns were treated mainly in hospitals and clinics or other ways, with hospitals being the main treatment site, accounting for 49.4% in 2019.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
3M
Molnlycke Health Care
Smith & Nephew
ConvaTec
Paul Hartmann
Braun
Coloplast
Mimedx Group
Cardinal Health
Integra LifeSciences
MEBO
Organogenesis
Mpm Medical
Tianjin Darentang Pharmaceutical Jingwanhong Co. Ltd